Literature DB >> 2150587

Treatment of ovulatory and anovulatory dysfunctional uterine bleeding with oral progestogens.

I S Fraser1.   

Abstract

Six anovulatory and 10 ovulatory women with dysfunctional uterine bleeding (DUB) were treated with cyclical oral progestogens (norethisterone or medroxyprogesterone acetate). Anovulatory women were treated from day 12-25 and ovulatory from day 5-25, in doses of 5-10mg 3 times daily. Measured menstrual blood loss was effectively reduced from control to treatment cycles in both anovulatory (control cycle 131ml; treatment 80 and 64ml) and ovulatory women (control cycles 110 and 113ml; treatment 76 and 71 ml). Three women with ovulatory DUB did not show a useful response. Duration of bleeding was reduced in both groups and the pattern of loss changed. These regimens are effective forms of management for most women with ovulatory or anovulatory DUB.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2150587     DOI: 10.1111/j.1479-828x.1990.tb02028.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  7 in total

Review 1.  Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation.

Authors:  Jerilynn C Prior
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

Review 2.  Progestogens with or without oestrogen for irregular uterine bleeding associated with anovulation.

Authors:  Martha Hickey; Jenny M Higham; Ian Fraser
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

3.  Medroxyprogesterone Acetate for Abnormal Uterine Bleeding Due to Ovulatory Dysfunction: The Effect of 2 Different-Duration Regimens.

Authors:  Rukiye Ada Bender
Journal:  Med Sci Monit       Date:  2022-06-24

Review 4.  Benefits and risks of pharmacological agents used for the treatment of menorrhagia.

Authors:  Samendra Nath Roy; Siladitya Bhattacharya
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

5.  Heavy menstrual flow: current and future trends in management.

Authors:  Yusuf Beebeejaun; Rajesh Varma
Journal:  Rev Obstet Gynecol       Date:  2013

6.  Medical therapy versus radiofrequency endometrial ablation in the initial treatment of heavy menstrual bleeding (iTOM Trial): A clinical and economic analysis.

Authors:  Abimbola O Famuyide; Shannon K Laughlin-Tommaso; Sherif A Shazly; Kirsten Hall Long; Daniel M Breitkopf; Amy L Weaver; Michaela E McGree; Sherif A El-Nashar; Maureen A Lemens; Matthew R Hopkins
Journal:  PLoS One       Date:  2017-11-15       Impact factor: 3.240

7.  The effectiveness of desogestrel for endometrial protection in women with abnormal uterine bleeding-ovulatory dysfunction: a non-inferiority randomized controlled trial.

Authors:  Nisarath Soontrapa; Manee Rattanachaiyanont; Malee Warnnissorn; Thanyarat Wongwananuruk; Suchada Indhavivadhana; Prasong Tanmahasamut; Kitirat Techatraisak; Surasak Angsuwathana
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.